Home » Topics » BioWorld Science

BioWorld Science
RSS

Novo Nordisk discovers GIP-R/GLP-1 receptor coagonists

Feb. 17, 2022

Enanta Pharmaceuticals describes SARS-CoV-2 3C-like proteinase inhibitors

Feb. 17, 2022

Pyruvate kinase isozyme M2 activators identified at the University of Michigan

Feb. 17, 2022

MAL protein seen to regulate epithelial-mesenchymal transition in gastric cancer

Feb. 17, 2022

Financing at Third Harmonic Bio to support development of oral KIT inhibitor THB-001

Feb. 16, 2022

YTHDF1 is involved in renal fibrosis through upregulation of YAP

Feb. 16, 2022

Memo Therapeutics to advance lead programs

Feb. 16, 2022

NIBIOHN and Shionogi announce discovery of novel antiviral antibody for SARS-CoV-2

Feb. 16, 2022

Persistent Ebolavirus in brain seeds relapses

Feb. 16, 2022

NTS-104 reduces critical neuroinflammatory signaling in rat embolic stroke model

Feb. 16, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...